3 ms·
I think this is a legitimate question. In my mind, there are two main issues. The first is what other alternatives would be overlooked because of an approved t
by toast0 5y ago
I think this is a legitimate question.
In my mind, there are two main issues. The first is what other alternatives would be overlooked because of an approved treatment, including further research.
The other issue is money. These medicines cost a lot of money, and it there's no improvement it's a waste of resources not only for the patient, but also for the insurance pool they're in. If it's something that's not expensive, go nuts, but thousands of dollars to move the metric but not the symptoms doesn't make sense to me.